Editors' Picks
Eight Phase 3 Trials, 29 Phase 2 Readouts, and a Diversifying Pipeline: Eyes on Alzheimer’s in 2026
2026-06-02
GSK Bolsters Oncology Portfolio With $10.6 Billion Nuvalent Acquisition in its Third Major Deal in 2026
On June 9, 2026, GSK announced a definitive agreement to acquire Nuvalent, a Boston-based clinical-stage biopharma company specialized in creating precisely targeted oncology therapies. The …
2026-06-09
Advanced Biologics & Biosimilars
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
As geopolitical tensions, the U.S. Biosecure Act, and reshoring initiatives reshape global pharmaceutical manufacturing, Taiwan-based EirGenix is positioning itself at the intersection of CDMO growth …
2026-06-11
HanchorBio Presents Next Generation Tri-specific Biologics and Manufacturing Strategies at Biologics World Taiwan 2026
Industry leaders gathered in Biologics World Taiwan 2026 to explore new biopharmaceutical developments and manufacturing strategies. HanchorBio Founder and CEO Dr. Scott Liu and Chemistry …
2026-05-14
LATEST
Markets & Deals
Ranking & Reports
VIDEOS
Categories
Cruise Ship Hantavirus Outbreak Revives COVID-19 Era Fears as WHO Says Public Risk Remains Low
2026-05-13
Nipah Virus Resurgence in South Asia: Health Authorities Ramp Up Surveillance Amid Fresh Outbreak Fears
2026-01-29
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan








